Aspo Plc
Aspo Plc: Share repurchase 6.11.2025
Aspo Plc: Share repurchase 6.11.2025
| Aspo Plc | ANNOUNCEMENT | 6.11.2025 |
| Aspo Plc: Share repurchase 6.11.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 6.11.2025 | |
| Bourse trade | Buy | |
| Share | ASPO | |
| Amount | 1 300 | Shares |
| Average price/ share | 6,8077 | EUR |
| Total cost | 8 850,01 | EUR |
| Aspo Plc now holds a total of 8 068 shares | ||
| including the shares repurchased on 6.11.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Aspo Plc | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
| For more information, please contact: | ||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | ||
| www.aspo.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S6.11.2025 19:00:56 CET | Press release
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
BONDUELLE6.11.2025 18:00:00 CET | Press release
BONDUELLE - Quarter 1 FY 2025-2026 Sales: The Bonduelle Group confirms its resilience in a demanding environment
Verkkokauppa.com Oyj6.11.2025 18:00:00 CET | Press release
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Vivoryon Therapeutics N.V.6.11.2025 17:31:00 CET | Press release
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
Chemometec A/S6.11.2025 17:11:48 CET | Pressemeddelelse
Vækst i omsætning og driftsresultat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom